MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Olfactory Impairment in Parkinson’s Disease and White Matter Abnormalities in Central Olfactory Areas

S. Sobhani, M. Aarabi (Tehran, Islamic Republic of Iran)

Meeting: 2017 International Congress

Abstract Number: 1531

Keywords: Magnetic resonance imaging(MRI), Olfactory dysfunction, Parkinsonism

Session Information

Date: Thursday, June 8, 2017

Session Title: Parkinson's Disease: Neuroimaging And Neurophysiology

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To determine white matter abnormalities in PD patients with various degrees of olfactory impairment.

Background: Neuroimaging results of PD brain based on diffusion tensor imaging(DTI)correlate well with the olfactory loss in PD patients.In the present study we aim to determine whether white matter integrity measured based on DTI method is associated with odor identification test scores in PD patients.

Methods: Data used in the preparation of this article were obtained from the Parkinson’s Progression Markers Initiative (PPMI) database. Odor identification was assessed using the University of Pennsylvania Smell Identification Test(UPSIT).

Five groups, total 85 subjects (18 anosmia, 26, 17 and 12 PD patients with severe, moderate and mild microsmia, respectively and 12 PD patients with normal olfactory status) were recruited with similar age, sex ratio, GDS, MoCA, handed and NHY.

The Diffusion MRI data were corrected for subject motion, eddy current distortions, and susceptibility artefacts due to the magnetic field inhomogeneity using Explore DTI toolbox [2]. Diffusion MRI connectometry was conducted in all subgroups using a multiple regression model considering UPSIT, sex, age and the local significant connectomes.

Results: The between-group Connectometry revealed that individuals with PD-Anosmia had lower QA(FDR=0.02123)in body of the corpus callosum (CC),bilateral corticospinal tracts,middle cerebellar peduncles,right and left cingulate cortex,left fornix,Genu and splenium of corpus callosum compared to patients with mild microsmia[Figure 1].A significant difference(FDR=0.04683)was observed in body,Genu and Splenium of the corpus callosum(CC)and bilateral corticospinal tracts between PD-anosmia and patients with moderate microsmia[Figure 2].individuals with Severe microsmia had alterations in FA in multiple regions(FDR=0.07658),including the right and left cingulate cortex, bilateral corticospinal tracts, middle cerebellar peduncles and left inferior longitudinal fasciculus(ILF)compared to mild microsmia patients[Figure 3].

Conclusions: This study shed light on the microstructural changes in bilateral cingulum, CC, IFOF, CST and MCP areas associated with olfactory impairment in early diagnosed PD patients. Since smell insufficiency is the precursor to PD, microstructural changes regarding reduced FA values in olfactory regions might reflect the primitive alterations in Parkinsonic brain.

References: 1. Ibarretxe-Bilbao, N., et al., Olfactory impairment in Parkinson’s disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study. Mov Disord, 2010. 25(12): p. 1888-94.

2. Doty, R.L., et al., University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope, 1984. 94(2 Pt 1): p. 176-8.

To cite this abstract in AMA style:

S. Sobhani, M. Aarabi. Olfactory Impairment in Parkinson’s Disease and White Matter Abnormalities in Central Olfactory Areas [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/olfactory-impairment-in-parkinsons-disease-and-white-matter-abnormalities-in-central-olfactory-areas/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/olfactory-impairment-in-parkinsons-disease-and-white-matter-abnormalities-in-central-olfactory-areas/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley